Related Experiment Video
Updated: Mar 30, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
A multi-institution evaluation of clinical profile anonymization
Raymond Heatherly1, Luke V Rasmussen2, Peggy L Peissig3
1Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA.
Anonymizing electronic health records (EHRs) using k-anonymization at multiple medical centers is feasible. Applying this to the entire EHR system significantly reduces data generalization, enabling secure sharing for phenome-wide association studies.
Area of Science:
- Health Informatics
- Biomedical Data Science
- Privacy-Preserving Technologies
Background:
- Growing need to share de-identified electronic health records (EHRs) for secondary research.
- Concerns exist regarding patient identity compromise from clinical terms in EHRs.
- Existing anonymization algorithm evaluations are limited to single institutions.
Purpose of the Study:
- To evaluate the performance of a k-anonymization algorithm across multiple medical centers.
- To assess the impact of anonymization context (entire EHR, biorepository, specific study) on data utility.
- To determine the effectiveness of anonymization in safeguarding patient privacy while enabling data sharing.
Main Methods:
- Applied a state-of-the-art k-anonymization algorithm (k=5) to International Classification of Disease, ninth edition codes.
- Utilized patient data from three medical centers: Marshfield Clinic, Northwestern University, and Vanderbilt University.
- Assessed anonymization utility by examining dataset size, code inclusion, and required generalization/suppression levels across different population contexts.
Main Results:
- Anonymizing within the entire EHR system significantly increased data quantity by reducing generalized regions from ~15% to ~0.5%.
- Approximately 70% of codes requiring generalization were only generalized to two or three codes in the largest anonymization context.
- The k-anonymization approach demonstrated effectiveness across different population levels and institutions.
Conclusions:
- Sharing large volumes of clinical data for phenome-wide association studies is achievable.
- The implemented anonymization strategy effectively safeguards individual patient privacy.
- Multi-institutional evaluation confirms the robustness of the anonymization approach for EHR data.
More Related Videos
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Preclinical Development: Overview
Censoring Survival Data
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

